Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C14H10ClF3N2O |
| Molecular Weight | 314.69 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC(F)(F)[C@]1(NC(=O)NC2=C1C=C(Cl)C=C2)C#CC3CC3
InChI
InChIKey=JJWJSIAJLBEMEN-ZDUSSCGKSA-N
InChI=1S/C14H10ClF3N2O/c15-9-3-4-11-10(7-9)13(14(16,17)18,20-12(21)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H2,19,20,21)/t13-/m0/s1
| Molecular Formula | C14H10ClF3N2O |
| Molecular Weight | 314.69 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Potency of nonnucleoside reverse transcriptase inhibitors (NNRTIs) used in combination with other human immunodeficiency virus NNRTIs, NRTIs, or protease inhibitors. | 2002-06 |
|
| 4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors. | 2001-06-04 |
|
| Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of HIV-1 non-nucleoside reverse transcriptase. | 2001-02-12 |
|
| 3,3a-Dihydropyrano[4,3,2-de]quinazolin-2(1H)-ones are potent non-nucleoside reverse transcriptase inhibitors. | 2001-01-22 |
|
| Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors. | 2000-05-18 |
|
| Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors. | 2000-01-17 |
|
| Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1. | 1999-12 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:05:25 GMT 2025
by
admin
on
Mon Mar 31 22:05:25 GMT 2025
|
| Record UNII |
I9U2GRQ1UF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
214287-88-4
Created by
admin on Mon Mar 31 22:05:25 GMT 2025 , Edited by admin on Mon Mar 31 22:05:25 GMT 2025
|
PRIMARY | |||
|
100000127544
Created by
admin on Mon Mar 31 22:05:25 GMT 2025 , Edited by admin on Mon Mar 31 22:05:25 GMT 2025
|
PRIMARY | |||
|
SUB33629
Created by
admin on Mon Mar 31 22:05:25 GMT 2025 , Edited by admin on Mon Mar 31 22:05:25 GMT 2025
|
PRIMARY | |||
|
I9U2GRQ1UF
Created by
admin on Mon Mar 31 22:05:25 GMT 2025 , Edited by admin on Mon Mar 31 22:05:25 GMT 2025
|
PRIMARY | |||
|
474120
Created by
admin on Mon Mar 31 22:05:25 GMT 2025 , Edited by admin on Mon Mar 31 22:05:25 GMT 2025
|
PRIMARY | |||
|
DTXSID30175699
Created by
admin on Mon Mar 31 22:05:25 GMT 2025 , Edited by admin on Mon Mar 31 22:05:25 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
